Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 16 ... grafting (CABG). Patients received either 20 mg/d enalapril or placebo for 6 days. Tissue-type plasminogenactivator (TPA), plasminogenactivator inhibitor-1 (PAI-1), ...
2009 NOV 9 ... (National Institutes of Health Stroke Scale scores, 0 to 10) and received intravenous tissue plasminogen activator. Day 1 DWI disclosed minimal changes in all patients. was favorable in all patients (day ...
2009 NOV 2 ... led to a basilar artery embolus and occlusion. A total of 15 mg of intraarterial tissue plasminogen activator was infused throughout the clot, followed by mechanical clot embolectomy using an ...
2009 NOV 9 ... fibronectin, vimentin, and type I and type III collagen expression; and reduced total tissue collagen content. Inhibition of ILK did not affect kidney structure or function in ... 1. Inhibition of ILK also blocked TGF-beta 1-mediated induction of fibronectin, Snail1, plasminogenactivator inhibitor 1, and matrix metalloproteinase 2. In a mouse model of obstructive ...
2009 NOV 23 ... is a leading cause of death and disability. The only therapy available is recombinant tissue plasminogen activator, but side effects limit its use." "Platelets play a crucial role during ...
2009 NOV 2 ... for central retinal vein occlusion: radial optic neurotomy (RON) and cannulation of tissue plasminogen activator (tPA) into the retinal vein (tPA). This study consisted of 22 eyes." "The ...
2009 NOV 2 ... induced moderate but significant changes in the expression of genes associated with tissue repair and inflammation. Among the top regulated genes, plasminogenactivator inhibitor ...
2009 NOV 23 ... According to recent research from Osaka, Japan, "Tissue-type plasminogenactivator (t-PA) is approved for treatment of ischemic stroke patients, ...
2009 NOV 9 ... who received an EVD (n = 32). The treatment algorithm started with IVF (4 mg recombinant tissue plasminogen activator every 12 hours) until clearance of the third and fourth ventricles from blood. ...
2009 NOV 16 ... a mean of 3.5 hours of symptom onset. Eleven patients received intravenous recombinant tissue-plasminogenactivator (rt-PA). HT was determined by follow-up computed tomography and/or ...
2009 NOV 2 ... vasodilators (sodium nitroprusside, 2-8 mu g/min; verapamil, 10-100 mu g/min). Tissue plasminogen activator (t-PA) was measured in venous plasma before and during bradykinin infusions. with COPD ...
2009 NOV 9 ... that leads to thrombosis. Evidence indicates that annexin A2 (A2), a receptor for tissue plasminogen activator and plasminogen, binds beta(2)GPI on target cells." "However, whether A2 ...
2009 NOV 23 ... by analyzing the lesion patterns following systemic thrombolysis with recombinant tissue plasminogen activator (rtPA) and tirofiban in middle cerebral artery (MCA) stroke. One hundred three ...
2009 NOV 9 ... "Trials of IV recombinant tissue plasminogen activator (rt-PA) have demonstrated that longer times from ischemic stroke symptom onset to ...
2009 NOV 23 ... receptor activator of nuclear factor-kappaB ligand (RANKL), gelatinases and tissue-type plasminogenactivator in U2OS cells (from the human osteosarcoma cell line) ...
2009 NOV 16 ... in many carcinomas. However, limited information about its expression in breast cancer tissue is available." "Therefore, we carried out an analysis on L1 expression in ... with nodal involvement, high grading, human epidermal growth receptor 2 (Her-2), plasminogenactivator inhibitor 1 (PAI-1) and vascular endothelial growth factor (VEGF) expression ...
2009 NOV 9 ... and protein levels of MMP-2, u-PA, urokinase-plasminogenactivator receptor (u-PAR), tissue inhibitor of metalloproteinase-2 (TIMP-2), plasminogenactivator inhibitor-1 (PAI-1), ...
2009 NOV 9 ... Current study results from the report, 'Tissue-type plasminogenactivator-plasmin-BDNF modulate glutamate-induced phase-shifts of the ...
2009 NOV 9 ... Mellitus, Kidney Transplant, Organ Transplant, Pancreas Transplant, Plasminogen, Tissue Engineering, Transplantation, Type 1 Diabetes. This article was prepared by ... (soluble intercellular, vascular cell-adhesion molecules, E-selectin, and plasminogen-activator-inhibitor-1) were measured in 10 T1DM patients after SPK with non-diabetic glucose ...
2009 NOV 2 ... This is in contrast to fibrinolytic factors as plasminogen-activator inhibitor I and tissue-type plasminogenactivator, which are affected," wrote C.J.N. Verkleij and colleagues, ...
